Skip to Main Content

Author Details

Sabine Behrens
German Cancer Research Center (DKFZ)
1993
68
19
PMIDPaper TitleJournal TitlePublished Year
37950650Cancer-related fatigue: Towards a more targeted approach based on classification by biomarkers and psychological factors.Int J Cancer2024
37950787Does breast cancer modify the long-term relationship between lifestyle behaviors and mortality? A prospective analysis of breast cancer survivors and population-based controls.Cancer2024
36824750Association of the CHEK2 c.1100delC variant, radiotherapy, and systemic treatment with contralateral breast cancer risk and breast cancer-specific survival.Res Sq2023
37964298Circulating oxysterols and prognosis among women with a breast cancer diagnosis: results from the MARIE patient cohort.BMC Med2023
37501086The impact of cardiovascular disease on all-cause and cancer mortality: results from a 16-year follow-up of a German breast cancer case-control study.Breast Cancer Res2023
37451831Evaluation of European-based polygenic risk score for breast cancer in Ashkenazi Jewish women in Israel.J Med Genet2023
37444426Spectrum and Frequency of Germline <i>FANCM</i> Protein-Truncating Variants in 44,803 European Female Breast Cancer Cases.Cancers (Basel)2023
37069615Postdiagnosis circulating osteoprotegerin and TRAIL concentrations and survival and recurrence after a breast cancer diagnosis: results from the MARIE patient cohort.Breast Cancer Res2023
37093543Longitudinal changes of health-related quality of life over 10 years in breast cancer patients treated with radiotherapy following breast-conserving surgery.Qual Life Res2023
37355720Endogenous estrogen receptor modulating oxysterols and breast cancer prognosis: Results from the MARIE patient cohort.Br J Cancer2023
36707629FANCM missense variants and breast cancer risk: a case-control association study of 75,156 European women.Eur J Hum Genet2023
35084436Pathology of Tumors Associated With Pathogenic Germline Variants in 9 Breast Cancer Susceptibility Genes.JAMA Oncol2022
35585550Breast cancer risks associated with missense variants in breast cancer susceptibility genes.Genome Med2022
35723569Distinct Reproductive Risk Profiles for Intrinsic-Like Breast Cancer Subtypes: Pooled Analysis of Population-Based Studies.J Natl Cancer Inst2022
36342239Association of circulating free and total oxysterols in breast cancer patients.Clin Chem Lab Med2022
36303815A genome-wide gene-based gene-environment interaction study of breast cancer in more than 90,000 women.Cancer Res Commun2022
36328784Physical activity, sedentary time and breast cancer risk: a Mendelian randomisation study.Br J Sports Med2022
36395613Changes in cigarette smoking behavior among breast cancer and unaffected women - A prospective study in the MARIE cohort.Cancer Epidemiol2022
35042965Rare germline copy number variants (CNVs) and breast cancer risk.Commun Biol2022
32359158Combined Associations of a Polygenic Risk Score and Classical Risk Factors With Breast Cancer Risk.J Natl Cancer Inst2021
33924513Health-Related Quality of Life in a Cohort of Breast Cancer Survivors over More Than 10 Years Post-Diagnosis and in Comparison to a Control Cohort.Cancers (Basel)2021
33668004Tired of feeling tired - The role of circulating inflammatory biomarkers and long-term cancer related fatigue in breast cancer survivors.Breast2021
33500318Breast Cancer Risk Factors and Survival by Tumor Subtype: Pooled Analyses from the Breast Cancer Association Consortium.Cancer Epidemiol Biomarkers Prev2021
34876619Association of circulating leptin, adiponectin, and resistin concentrations with long-term breast cancer prognosis in a German patient cohort.Sci Rep2021
34407845Association of germline genetic variants with breast cancer-specific survival in patient subgroups defined by clinic-pathological variables related to tumor biology and type of systemic treatment.Breast Cancer Res2021
34611289Germline variants and breast cancer survival in patients with distant metastases at primary breast cancer diagnosis.Sci Rep2021
34146516Functional annotation of the 2q35 breast cancer risk locus implicates a structural variant in influencing activity of a long-range enhancer element.Am J Hum Genet2021
34341517Mendelian randomisation study of smoking exposure in relation to breast cancer risk.Br J Cancer2021
33221667Changes in alcohol consumption, body weight and physical activity among breast cancer survivors and population-based unaffected women in a prospective study.Cancer Epidemiol2021
33395600The effect of family history on screening procedures and prognosis in breast cancer patients - Results of a large population-based case-control study.Breast2021
33471991Breast Cancer Risk Genes - Association Analysis in More than 113,000 Women.N Engl J Med2021
33259052Comorbidity burden in long-term breast cancer survivors compared with a cohort of population-based controls from the MARIE study.Cancer2021
32621760Postdiagnosis weight change is associated with poorer survival in breast cancer survivors: A prospective population-based patient cohort study.Int J Cancer2021
31617773Prognostic associations of circulating phytoestrogens and biomarker changes in long-term survivors of postmenopausal breast cancer.Nutr Cancer2020
31949161A network analysis to identify mediators of germline-driven differences in breast cancer prognosis.Nat Commun2020
33022221Breast Cancer Polygenic Risk Score and Contralateral Breast Cancer Risk.Am J Hum Genet2020
32554541Development and Validation of the Gene Expression Predictor of High-grade Serous Ovarian Carcinoma Molecular SubTYPE (PrOTYPE).Clin Cancer Res2020
32473302Prognostic gene expression signature for high-grade serous ovarian cancer.Ann Oncol2020
31605532Assessment of interactions between 205 breast cancer susceptibility loci and 13 established risk factors in relation to breast cancer risk, in the Breast Cancer Association Consortium.Int J Epidemiol2020
30327309Association of CD4<sup>+</sup> Radiation-Induced Lymphocyte Apoptosis with Fibrosis and Telangiectasia after Radiotherapy in 272 Breast Cancer Patients with &gt;10-Year Follow-up.Clin Cancer Res2019
31694687Pre- to postdiagnosis leisure-time physical activity and prognosis in postmenopausal breast cancer survivors.Breast Cancer Res2019
31239549A combination of the immunohistochemical markers CK7 and SATB2 is highly sensitive and specific for distinguishing primary ovarian mucinous tumors from colorectal and appendiceal metastases.Mod Pathol2019
30668630Antioxidant supplementation and breast cancer prognosis in postmenopausal women undergoing chemotherapy and radiation therapy.Am J Clin Nutr2019
29248876Associations between adjuvant radiotherapy and different causes of death in a German breast cancer cohort.Breast2018
29974464Circulating enterolactone concentrations and prognosis of postmenopausal breast cancer: assessment of mediation by inflammatory markers.Int J Cancer2018
30134598rs495139 in the TYMS-ENOSF1 Region and Risk of Ovarian Carcinoma of Mucinous Histology.Int J Mol Sci2018
30062862Association of p16 expression with prognosis varies across ovarian carcinoma histotypes: an Ovarian Tumor Tissue Analysis consortium study.J Pathol Clin Res2018
29763737Validation of inflammatory genetic variants associated with long-term cancer related fatigue in a large breast cancer cohort.Brain Behav Immun2018
28670784Gene-environment interactions involving functional variants: Results from the Breast Cancer Association Consortium.Int J Cancer2017
28179588TP53-based interaction analysis identifies cis-eQTL variants for TP53BP2, FBXO28, and FAM53A that associate with survival and treatment outcome in breast cancer.Oncotarget2017
  • 1 - 50 of 68

Recommended Authors

Princess Margaret Cancer Centre, University Health Network
Career Start Year 2013
Number of shared co-authors 0
Netherlands Cancer Institute
Career Start Year 2012
Number of shared co-authors 18
Indiana University School of Medicine
Career Start Year 2011
Number of shared co-authors 0
Queen Mary Universityof London
Career Start Year 2010
Number of shared co-authors 1
Mater Misericordiae University Hospital
Career Start Year 2006
Number of shared co-authors 5
Nagoya City University Graduate School of Medical Sciences
Career Start Year 2006
Number of shared co-authors 25
University of California San Francisco
Career Start Year 2005
Number of shared co-authors 15
Columbia University Irving Medical Center
Career Start Year 2004
Number of shared co-authors 3
Clinical Investigations Branch, National Cancer Institute
Career Start Year 2004
Number of shared co-authors 16
University of Washington
Career Start Year 2004
Number of shared co-authors 2
National Cancer Institute
Career Start Year 2004
Number of shared co-authors 33
University of Arizona
Career Start Year 2003
Number of shared co-authors 0
King Edward Memorial Hospital
Career Start Year 2002
Number of shared co-authors 0
The First Hospital of Lanzhou University
Career Start Year 2002
Number of shared co-authors 0
University of Cambridge
Career Start Year 2000
Number of shared co-authors 9
Champalimaud Clinical Center/Champalimaud Foundation
Career Start Year 2000
Number of shared co-authors 11
Department of Medicine and Moores Cancer Center, University of California San Diego
Career Start Year 2000
Number of shared co-authors 1
Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center
Career Start Year 1998
Number of shared co-authors 52
Southern California Permanente Medical Group
Career Start Year 1998
Number of shared co-authors 2
Dana Farber Cancer Institute.
Career Start Year 1997
Number of shared co-authors 9
Institut de Recherche en Cancerologie de Montpellier
Career Start Year 1993
Number of shared co-authors 15
The University of Texas MD Anderson Cancer Center
Career Start Year 1993
Number of shared co-authors 6
Center for Translational Oncology, Cancer Institute of the State of Sao Paulo - ICESP
Career Start Year 1993
Number of shared co-authors 2
Center for Cancer Equity and Engagement, Dana-Farber/Harvard Cancer Center
Career Start Year 1991
Number of shared co-authors 103
Fred Hutchinson Cancer Research Center
Career Start Year 1991
Number of shared co-authors 10
Princess Margaret Cancer Centre
Career Start Year 1991
Number of shared co-authors 4
National Cancer Institute.
Career Start Year 1990
Number of shared co-authors 32
Karolinska Institute
Career Start Year 1988
Number of shared co-authors 7
University of California San Francisco
Career Start Year 1984
Number of shared co-authors 102
Albert Einstein College of Medicine
Career Start Year 1980
Number of shared co-authors 39

Collaborators

German Cancer Research Center (DKFZ)
Co-authored papers 64
Center for Cancer Genetic Epidemiology, University of Cambridge
Co-authored papers 37
University of Cambridge
Co-authored papers 34
Otto-Friedrich-University Bamberg
Co-authored papers 33
National Cancer Institute
Co-authored papers 33
Co-authored papers 33
Co-authored papers 33
Co-authored papers 28
University of Toronto
Co-authored papers 27
Co-authored papers 27
Mayo Clinic
Co-authored papers 27
QIMR Berghofer Medical Research Institute
Co-authored papers 24
Co-authored papers 23
Pomeranian Medical University
Co-authored papers 23
Faculty of Clinical Medicine, University of Oslo
Co-authored papers 22
Instituto de Salud Carlos III
Co-authored papers 21
The Usher Institute, The University of Edinburgh
Co-authored papers 21
National Cancer Institute, National Institutes of Health
Co-authored papers 20
Co-authored papers 19
University of California irvine
Co-authored papers 19
University of Southern California
Co-authored papers 18
Mayo Clinic
Co-authored papers 16
Ospedale Circolo e Fondazione Macchi
Co-authored papers 16
Harvard T. H. Chan School of Public Health
Co-authored papers 16
Co-authored papers 16
Co-authored papers 15
Co-authored papers 13
Co-authored papers 12
Mayo Clinic
Co-authored papers 12
The M. Sklodowska-Curie Cancer Center and Institute of Oncology
Co-authored papers 12